Rising drug costs barrier to patient care

The age-old question of whether patient care is negatively affected by rising drug costs is the focus of “The Impact of Drug Pricing on Access to Care: Demystifying the Landscape” (UO13) from 7:30 to 8:30 a.m. Friday in Room 140B.

Shadi Kourosh, MD, Elise A. Olsen, MD, Len M. Nichols, PhD, and Jonathan Jarrow, MD, tackle the tough topic, bringing issues of patient value and outcomes to the forefront of the discussion. Unfortunately, rising medication costs are affecting the way patients are treated, insist the three speakers. Without well-documented value, dermatology patients are often denied coverage, due to more stringent insurance utilization of review tools.

This session will provide attendees with an overview of the hurdles to quality medical care, including narrowing drug formularies, prior authorizations, step therapy, and what’s commonly referred to as “specialty tiers.”

Further discussion will focus on possible solutions to the problem by detailing the current health care environment related to drug pricing, legislative and health agency involvement, and strategies on how dermatologists can collaborate with patients and stakeholders to improve the current situation.

Attendees can earn 1.0 CME credit for the session; no tuition or ticket is required.

Return to index